Gwenn Hansen
2019
In 2019, Gwenn Hansen earned a total compensation of $695.4K as Chief Scientific Officer at Nurix Therapeutics.
Compensation breakdown
| Bonus | $298,800 |
|---|---|
| Option Awards | $93,937 |
| Salary | $299,167 |
| Other | $3,500 |
| Total | $695,404 |
Hansen received $299.2K in salary, accounting for 43% of the total pay in 2019.
Hansen also received $298.8K in bonus, $93.9K in option awards and $3.5K in other compensation.
Rankings
In 2019, Gwenn Hansen's compensation ranked 10,708th out of 13,971 executives tracked by ExecPay. In other words, Hansen earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,708 out of 13,971 | 23rd |
Division Manufacturing | 4,336 out of 5,701 | 24th |
Major group Chemicals And Allied Products | 1,684 out of 2,200 | 24th |
Industry group Drugs | 1,441 out of 1,886 | 24th |
Industry Pharmaceutical Preparations | 1,067 out of 1,398 | 24th |
Source: SEC filing on March 25, 2021.
Hansen's colleagues
We found one more compensation record of an executive who worked with Gwenn Hansen at Nurix Therapeutics in 2019.
2019
Arthur Sands
Nurix Therapeutics
Chief Executive Officer
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021